Resistance to 1,25D-induced differentiat
✍
Edward Garay; Robert Donnelly; Xuening Wang; George P. Studzinski
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 438 KB
## Abstract The anti‐neoplastic effects of 1,25‐dihydroxyvitamin D~3~ (1,25D) are well documented in numerous tumor cell systems and animal models of cancer. However, despite this pre‐clinical success, the clinical use of 1,25D is currently impeded by the dose‐limiting hypercalcemia, and the risk o